CRISPR and Genome Editing – News and Features

The California Institute of Technology has been awarded $2.3 million from the California Institute for Regenerative Medicine

The Keck School of Medicine received the largest portion of the new funds from California Institute for Regenerative Medicine.

Mesoporous nanospheres could deliver drugs to cancer cells while leaving healthy cells unharmed.

Aldevron purchases synDNA™ to offer a broader range of solutions to gene therapy and DNA vaccine researchers.

The TrueClone™ Collection allows scientists to easily query the roles of genes in disease phenotypes and pathways.

The strategy might be used to protect animals against influenza or foot-and-mouth disease.

Researchers use computational methods to predict what could be a prokaryotic RNA-silencing mechanism similar to the eukaryotic RNAi system.

Nanotechnology drug-delivery companies seeking to partner with pharmaceutical companies face competition from a plethora of available drug-delivery systems.

Progress made toward developing next generation molecular medicines to treat obesity and type 2 diabetes.

Now in its second year, the SCIpharm 2006 conference (May 14-17, EICC, Edinburgh, Scotland) will cover all aspects of modern R&D in a four-track format - Gene to Screen, Screen to Candidate, Candidate to Drug and Where Science Meets Business.